7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,488.00

+455.87

+0.59%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

TSXV - Delayed Quote CAD

BioSyent Inc. (RX.V)

17.09 +0.26 (+1.54%)

At close: October 30 at 3:51:20 PM EDT

Loading Chart for RX.V

Chart Range Bar

Interval:

In partnership with ChartIQ

BioSyent to Present at Planet MicroCap Toronto

BioSyent to Present at Planet MicroCap Toronto

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

BioSyent Declares Third Quarter 2026 Dividend

BioSyent Declares Third Quarter 2026 Dividend

BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026

BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026

BioSyent to Present at Planet MicroCap Las Vegas

BioSyent to Present at Planet MicroCap Las Vegas

BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)

BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)

BioSyent Declares Second Quarter 2026 Dividend

BioSyent Declares Second Quarter 2026 Dividend

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

BioSyent Announces Grant of Restricted Share Units

BioSyent Announces Grant of Restricted Share Units

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

Mobilize your Website

View Site in Mobile | Classic

Share by: